Fideuram Asset Management (Ireland)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.9M Buy
119,179
+105,517
+772% +$22.7M 0.49% 31
2026
Q1
$3.05M Sell
13,662
-47,589
-78% -$10.6M 0.39% 88
2025
Q4
$13.1M Buy
+61,251
New +$14M 1.04% 20

Other funds holding ABBV

Fideuram Asset Management (Ireland)'s ABBV Position: Q2 2026 in Review

Fideuram Asset Management (Ireland) increased its AbbVie (ABBV) stake by 772% in Q2 2026, buying an estimated $22.7M and bringing the position to 119,179 shares worth $25.9M. The position accounts for 0.49% of the portfolio, ranked #31.

Fideuram Asset Management (Ireland) first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fideuram Asset Management (Ireland) held 119,179 shares of AbbVie worth $25.9M as of Q2 2026.
  • Fideuram Asset Management (Ireland) bought 105,517 AbbVie shares in Q2 2026, an estimated $22.7M.
  • AbbVie made up 0.49% of Fideuram Asset Management (Ireland)'s portfolio in Q2 2026, its #31 holding.
  • Fideuram Asset Management (Ireland) first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fideuram Asset Management (Ireland)'s 13F filing for Q2 2026, filed 23 Jul 2026.